Discover
CBLL
CeriBell, Inc.
20.00
2 x 14.33
2 x 25.08
bid
ask
+
0.55
2.83%
2 @ 04:00 PM
20.00 +0.00 (0.00%)
| Ytd | -8.80% | |
| 1y | 7.70% |
19.45
day range
20.20
10.85
52 week range
24.33
| Open | 19.45 | Prev Close | 19.45 | Low | 19.45 | High | 20.20 | Mkt Cap | 758.85M |
| Vol | 316.59K | Avg Vol | 318.85K | EPS | -1.62 | P/E | N/A | Forward P/E | -24.29 |
| Beta | N/A | Short Ratio | 2.68 | Inst. Own | 39.53% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 18.92 | 200-d Avg | 17.79 | 1yr Est | 33.25 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2025-02-11 | 2024-12 | -0.32 | N/A | N/A | N/A |
| 2024-11-12 | 2024-09 | -0.82 | -1.85 | -1.03 | -125.61% |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-12-09 | TD Cowen | Upgrade | Buy | Buy |
| 2024-12-09 | Canaccord Genuity | Upgrade | Buy | Buy |
| 2024-11-13 | Canaccord Genuity | Upgrade | Buy | Buy |
| 2024-11-05 | JP Morgan | Upgrade | Overweight | |
| 2024-11-05 | William Blair | Upgrade | Outperform | |
| 2024-11-05 | Canaccord Genuity | Upgrade | Buy |
Profile
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | Fidelity Strategic Advisers Fidelity U.S. Total Stock Fund | 400.00K | 10.69M | 1.12% |
| 2024-10-30 | Fidelity Balanced Fund | 364.10K | 9.73M | 1.02% |
| 2024-10-30 | Fidelity Select Portfolios - Medical Technology & Devices Port | 292.36K | 7.81M | 0.82% |
| 2024-10-30 | Fidelity Growth Company Fund | 256.80K | 6.86M | 0.72% |
| 2024-10-30 | Fidelity Advisor Equity Growth Fund | 110.50K | 2.95M | 0.31% |
| 2024-10-30 | Variable Insurance Products Fund-Growth Portfolio | 105.20K | 2.81M | 0.29% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|